Nigeria is West Africa's largest pharmaceutical market by volume, and its finished-dose manufacturers rely predominantly on Indian API imports to support the country's substantial generic drug production capacity. For Nigerian pharmaceutical bulk buyers evaluating Furosemide API supply relationships, the choice of furosemide API supplier in India determines NAFDAC (National Agency for Food and Drug Administration and Control) registration timelines, Lagos and Apapa port clearance efficiency, and long-term supply reliability for the Nigerian domestic and ECOWAS regional markets.
This guide profiles the ten most relevant Furosemide API exporter options for Nigerian bulk buyers, drawing from the broader Indian API manufacturing landscape and filtering for WHO-GMP certification standing, West African export experience, and documentation depth suitable for NAFDAC registration and ECOWAS market extension.
Comparison Overview: Top 10 Furosemide API Exporters for Nigerian Buyers
| # | Exporter | Base | Nigerian Market Relevance |
| 1 | Kodel Life | Morbi, Gujarat, India | ISO 9001:2015, FDA-compliant, direct Nigeria documentation support, 21-country export network |
| 2 | Aarti Drugs Ltd | Tarapur, Maharashtra, India | Large public listed API producer with West Africa export track record |
| 3 | Sri Krishna Pharma | Hyderabad, India | CEP + USFDA + EU approvals, exports to 75+ countries |
| 4 | Amsal Chem Pvt Ltd | Ahmedabad, India | Established Furosemide producer with pharmacopoeial depth |
| 5 | Salvavidas Pharmaceutical | Surat, Gujarat, India | WHO-GMP, active African market presence |
| 6 | Aurobindo Pharma Ltd | Hyderabad, India | Integrated pharma with commercial-scale cardiovascular API |
| 7 | Cipla Ltd | Mumbai, India | Historic African market presence including West Africa |
| 8 | Sun Pharmaceutical Industries | Mumbai / Vadodara, India | India's largest pharma, global API scale |
| 9 | Dr. Reddy's Laboratories | Hyderabad, India | Global API division with established African operations |
| 10 | Jai Radhe Sales | Ahmedabad, India | API distributor with African buyer service infrastructure |
01. Kodel Life - Direct Furosemide API Export to Nigeria
Kodel Life is a Furosemide API manufacturer operating from Morbi, Gujarat, India, under ISO 9001:2015 Quality Management System certification and FDA-compliant cGMP manufacturing practices. The company exports pharmaceutical API to 21 countries across 5 continents, with active export lanes into West Africa including Nigeria, Ghana, and Côte d'Ivoire. For Nigerian bulk buyers navigating NAFDAC registration for finished-dose products, Kodel Life provides Nigeria-specific documentation preparation covering apostille-certified WHO-GMP certificates, batch COAs to BP or USP grades, site master file summaries, ICH Q3A impurity profiles, and ICH Q1A stability data ready for NAFDAC dossier inclusion.
Shipments to Nigeria are typically routed through Mundra port (Gujarat) or Nhava Sheva (JNPT, Mumbai) to Apapa or Tin Can Island ports in Lagos, with typical sea freight transit times of 25 to 35 days. The Kodel Life documentation team handles Nigeria-specific customs paperwork requirements including apostille certification and NAFDAC pre-shipment notification support where required. Contact info@kodellife.com or call +91 75023 33335.
02. Aarti Drugs Ltd - Commercial-Scale Public Listed API Producer
Aarti Drugs, a public listed company established in 1984 and part of the Aarti Group of Industries, operates API manufacturing across facilities in Tarapur and Sarigam with a broad cardiovascular, anti-inflammatory, and anti-infective portfolio. The company's West African market export experience and commercial-scale batch availability position it as a viable option for Nigerian bulk buyers with recurring annual Furosemide API demand at commercial scale.
03. Sri Krishna Pharma (SKPL) - Multi-Authority GMP Standing
Sri Krishna Pharma, headquartered in Hyderabad, holds USFDA, TGA, and EU health authority GMP approvals along with CEP documentation for Furosemide. The company exports to over 75 countries including African markets. For Nigerian buyers whose finished-dose products may target ECOWAS regional markets or EU export opportunities in future, SKPL's multi-authority regulatory certification portfolio simplifies dossier support across multiple market registrations.
The certification framework distinctions between WHO-GMP (sufficient for NAFDAC), EU-GMP (required for European MA), and FDA inspection standing (required for US ANDA) affect the choice of Indian Furosemide API supplier for Nigerian buyers with regional or international export ambitions. The full framework is covered in the guide to WHO-GMP, DMF and CEP compliance for Indian API manufacturers.
04. Amsal Chem Pvt Ltd - Established Furosemide Producer
Amsal Chem, based in Ahmedabad, is listed among established Indian Furosemide API manufacturers on international pharmaceutical directories with pharmacopoeial-grade Furosemide documentation. Nigerian buyers evaluating Amsal Chem should verify current WHO-GMP certificate scope, pharmacopoeial grade availability, and West African export documentation experience during pre-qualification.
05. Salvavidas Pharmaceutical - Active African Export Operations
Salvavidas Pharmaceutical, based in Surat, Gujarat, operates as a WHO-GMP certified API manufacturer with reported active export operations across Asia, Africa, and Europe. The company's product portfolio spans cardiovascular, oncology, neurology, and anti-infective molecules, and its African market positioning makes it accessible to Nigerian buyers seeking a mid-tier alternative between large integrated pharma groups and small specialised Furosemide-focused producers.
Nigerian procurement teams applying a systematic comparison across multiple prospective Furosemide API exporters should use a consistent scoring framework covering GMP certification currency, DMF/CEP status, COA quality, and stability data depth. The Furosemide API bulk manufacturer India checklist provides a practical scoring template that Nigerian buyers can apply directly across the shortlist.
06. Aurobindo Pharma Ltd - Integrated Cardiovascular API Producer
Aurobindo Pharma, headquartered in Hyderabad, is one of India's largest integrated pharmaceutical manufacturers with a substantial API division covering antibiotics, antiretrovirals, cardiovascular, and CNS products. The company's African market export infrastructure and integrated pharmaceutical group scale support high-volume Furosemide API supply for Nigerian bulk buyers with commercial-scale requirements above 1,000 kg annually.
07. Cipla Ltd - Historic West African Market Commitment
Cipla, founded in 1935 in Mumbai, has decades of commitment to African pharmaceutical markets including West Africa. The company's African operations extend across multiple therapeutic areas, and its brand recognition within Nigerian and ECOWAS pharmaceutical markets is well-established. For Nigerian buyers, Cipla offers scale, regulatory documentation depth, and familiar brand relationships.
08. Sun Pharmaceutical Industries - Global API Leader
Sun Pharma, India's largest pharmaceutical company by market capitalisation, operates a substantial API manufacturing division with an established African export footprint. For Nigerian bulk buyers evaluating supplier scale and regulatory documentation depth simultaneously, Sun Pharma's combination of commercial infrastructure and multi-authority certification portfolio supports commercial-scale supply relationships.
09. Dr. Reddy's Laboratories - Sub-Saharan Africa Infrastructure
Dr. Reddy's Laboratories, headquartered in Hyderabad, maintains a substantial API division and formulation operations across Sub-Saharan Africa including West African regional presence. The company's cardiovascular API portfolio has served international generic drug manufacturers for over three decades, providing Nigerian buyers with combined API supply and regional technical support access.
Nigerian regulatory affairs teams preparing Furosemide API drug substance sections for NAFDAC dossiers benefit from understanding the manufacturing process and ICH Q7 controls that underpin the API's quality documentation. The Furosemide API manufacturing process guide covers synthesis route, cGMP controls, and impurity qualification that apply across all ten manufacturers on this list.
10. Jai Radhe Sales - API Distributor and Sourcing Partner
Jai Radhe Sales, founded in 1999 in Ahmedabad, operates as a global distributor of Indian pharmaceutical ingredients with technical and regulatory support services included in its distributor model. For Nigerian buyers with diverse API portfolio requirements and a preference for consolidated multi-molecule sourcing through a single supplier interface, distributor models such as Jai Radhe provide an alternative to managing direct relationships with multiple Indian manufacturers.
NAFDAC Registration Considerations for Nigerian Furosemide API Buyers
Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC) requires pharmaceutical products marketed in Nigeria to reference approved API sources on their product registration files. For a new Indian Furosemide API supplier to be added to a Nigerian finished-dose product registration, NAFDAC typically requires the manufacturer's WHO-GMP certificate (apostille-certified), site master file, batch COAs, ICH Q3A impurity profile, and ICH Q1A stability data.
The NAFDAC plant registration or supplier variation timeline typically ranges from six to fifteen months from submission, depending on documentation completeness and NAFDAC review capacity. Nigerian bulk buyers planning to add a new Furosemide API supplier should initiate the documentation collection process nine to twelve months before the intended finished-dose product launch date. Delays are commonly caused by missing apostille certification on the GMP certificate or incomplete stability data covering the required time points.
The export documentation and customs preparation at the Indian origin end of a Nigeria-bound Furosemide API shipment follows the standard Indian pharmaceutical API export framework. The Furosemide API export from India guide covers ITCHS classification, shipping bill preparation, and destination-market documentation requirements applicable to Nigerian shipments through Apapa or Tin Can Island ports.
Lagos Port Logistics: Apapa and Tin Can Island
Furosemide API sea freight into Nigeria is routed almost exclusively through the Port of Lagos, comprising two main container terminals: Apapa port and Tin Can Island port. Sea freight from Mundra (Gujarat) or Nhava Sheva (JNPT, Mumbai) to Lagos takes 25 to 35 days depending on shipping line schedule and West African port congestion, which can extend transit times during peak import season. Ensure that the shipping line schedule is confirmed before the API leaves the Indian factory to align QC release with expected sea freight departure.
Nigerian customs clearance for pharmaceutical API shipments requires the NAFDAC pre-shipment notification, import permit, and complete accompanying documentation including WHO-GMP certificate, COA, MSDS, COO, and shipping documents. Clearance times at Apapa and Tin Can Island typically range from one to three weeks depending on documentation completeness and customs workload. Working with an experienced Nigerian pharmaceutical customs broker significantly reduces clearance risk and demurrage exposure.
Nigeria Sourcing Success Comes Down to Documentation Timing
The ten manufacturers on this list all supply commercial-grade Furosemide API. The differentiating factor for successful long-term Nigerian bulk supply relationships is documentation timing: the supplier who provides apostille-certified NAFDAC documentation within five business days of a request, who prepares Nigeria-specific pre-shipment documentation before each shipment leaves Indian ports, and who is available for follow-up questions during the NAFDAC review process is the supplier who delivers actual value to a Nigerian bulk buyer.
Kodel Lifescience LLP provides NAFDAC-ready Furosemide API documentation as a standard service for qualified Nigerian buyers, with the regulatory affairs team available for direct dialogue during the NAFDAC review process. Contact info@kodellife.com or call +91 75023 33335 to request a Nigeria export quote and documentation package.
Request Nigeria Export Quote:
Contact Kodel Life for Nigeria-specific Furosemide API pricing, NAFDAC-ready apostille-certified documentation, and Lagos port shipping coordination. Email info@kodellife.com or call +91 75023 33335.
